STAT
APRIL 17, 2025
UnitedHealth Group on Thursday lowered its profit outlook for the rest of this year after the health care conglomerate said its Medicare Advantage members continued to seek more medical care than it anticipated. The higher use of care among these Medicare enrollees “was most notable within physician and outpatient services,” UnitedHealth said in its first-quarter earnings release.
Pharmaceutical Business Review
APRIL 17, 2025
The funding round was spearheaded by CTI Life Sciences Fund, Advent Life Sciences, and abrdn-managed funds. Current investors, including Sanofi Ventures, Novo Holdings, RiverVest Venture Partners, Sanderling Ventures, Abingworth, Chiesi Ventures, Asahi Kasei Ventures, and Remiges Ventures, also participated in the round. Glycomine noted that the therapy is being developed to treat the rare and potentially fatal phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Quality Matters
APRIL 17, 2025
Over half of the active pharmaceutical ingredients (API) for prescription medicines in the U.S. come from India and the European Union This blog is part of a series on the geographic concentration of pharmaceutical manufacturing. This blog focuses on the manufacturing of active pharmaceutical ingredients (API). For a discussion on finished dose manufacturing, seehere.
Putting Patients First Blog
APRIL 17, 2025
NHC Letter to Congress: Protect Medicaid Access for Americans with Chronic Conditions and Disabilities (PDF) April 17, 2025 The Honorable John Thune The Honorable Chuck Schumer Majority Leader Minority Leader United States Senate United States Senate Washington, DC 20510 Washington, DC 20510 The Honorable Mike Johnson The Honorable Hakeem Jeffries Speaker Minority Leader U.S.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
The Pharmacist
APRIL 17, 2025
Up to 200 additional pharmacies will be able to offer the respiratory syncytial virus (RSV) immunisation programme during 2025/26, under new plans announced by NHS England. This is on top of the around 40 community pharmacy sites that currently offer the national programme which is open to older adults and pregnant women. The update comes […] The post NHSE to expand community pharmacy RSV vaccine offer appeared first on The Pharmacist.
Pharmafile
APRIL 17, 2025
Allegros hydrocelin treatment for osteoarthritis has demonstrated a satisfactory safety profile, giving it potential to become a leading disease-modifying treatment for osteoarthritis. This was announced at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO) in Rome, Italy. The product, known as microparticle hydrogel hydrocelin, was announced as being non-pyrogenic following a series of […] The post Allegro confirms successful safety testing of osteoarthr
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
STAT
APRIL 17, 2025
WASHINGTON — The Food and Drug Administration will remove industry representatives from advisory committees and replace them with patients and caregivers, Commissioner Marty Makary announced Thursday. While that’s not really a big change, it’s the latest effort by Makary and his boss, health secretary Robert F. Kennedy Jr., to reduce the influence of the pharmaceutical industry.
European Pharmaceutical Review
APRIL 17, 2025
Over the past decade, we have witnessed the arrival of a new era in biopharmaceutical R&D. Traditional methods and processes, such as wet labs, are being augmented by a rapidly expanding digital ecosystem in pharma. Across the industry, this shift is offering extraordinary opportunities to increase the speed, accuracy, and reproducibility of research.
STAT
APRIL 17, 2025
Even before the Department of Health and Human Services announced its recent major reorganization, the media had been reporting on anticipated changes to the Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health. But the very last bullet on the HHS fact sheet was a complete surprise to most people: the elimination of the Administration for Community Living (ACL).
European Pharmaceutical Review
APRIL 17, 2025
Researchers in Spain have developed a new method to deliver cell therapies to patients on extracorporeal membrane oxygenation (ECMO), a life support system for severe lung failure. The consecutive intrabronchial administration (CIBA) method enables a new route of delivery: targeted, controlled, fractionated intrabronchial delivery. The researchers referred to the novel approach as slow consecutive intrabronchial lobe-by-lobe administration.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
APRIL 17, 2025
For a decade and a half, Americans have been guaranteed that no matter their health insurer, certain preventive care like cancer screenings are free of charge. That’s because an Affordable Care Act provision has required insurers to fully cover services given an A or B recommendation by an expert task force. That may soon change. On Monday, the U.S.
Pharma Marketing Network
APRIL 17, 2025
What do you do when the traditional pillars of your marketing strategy start to crumble? For many pharmaceutical companies in 2025, the answer is clear: pivot aggressively toward digital. With geopolitical volatility sparking new tariff threats and mounting legislative scrutiny over pharmaceutical television ads, pharma digital ad spend is experiencing a noticeable surge.
STAT
APRIL 17, 2025
RadNet, which runs nearly 400 radiology imaging centers in the United States, wants to put artificial intelligence into breast imaging. Over the last five years, the company has moved aggressively to expand its AI capabilities, deploying the technology for breast cancer screenings at its radiology practices. There, patients can pay $40 out-of-pocket for an algorithm to screen their mammogram, with a double-check if the AI says something different than the human radiologist reading the same
PharmaVoice
APRIL 17, 2025
The non-traditional marketing approach comes amid a potential crackdown on TV drug ads.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
APRIL 17, 2025
A daily pill from Eli Lilly helped patients with type 2 diabetes improve their blood sugar and shed weight, the company said Thursday, results that could propel the next-generation treatment onto the market. The drug, orforglipron, produced results that were nearly comparable to the benefits of available GLP-1 drugs, which are weekly injectable treatments.
Pharma Times
APRIL 17, 2025
More than 37 million adults in the US are affected by migraine
STAT
APRIL 17, 2025
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Buried in a leaked draft budget from the Trump administration is an ask that may alarm (or elate?) health tech watchers. The administration is proposing to create a new office of the chief technology officer within the federal health department that would house the Assi
PharmaVoice
APRIL 17, 2025
The federal health department sidestepped normal procedures as it laid off 10,000 employees, according to sources. One union has already filed an internal complaint, while at least two law firms are exploring suits.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
STAT
APRIL 17, 2025
GSK’s blood cancer drug Blenrep won regulatory approval in the U.K. on Thursday, marking the medicine’s return to the market after it was withdrawn several years ago. The drug, which treats multiple myeloma, will be used in combination with other medicines in patients whose cancer has resurged after an earlier line of treatment, under the approval from the Medicines and Healthcare products Regulatory Agency.
pharmaphorum
APRIL 17, 2025
Tariffs on US pharma imports could remove discounts offered to health systems by biosimilars and threaten the future of the sector, says a non-profit
STAT
APRIL 17, 2025
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. I cast my leafy-green seeds already, and my mint, chives and oregano are roaring back after wintering over. Send me planting suggestions that are appropriate for the Washington, DC, area at this time of year, and send news tips to John.Wilkerson@statnews.com or via Signa
EMCrit Project
APRIL 17, 2025
Neuroleptic Malignant Syndrome (NMS) and Serotonin Syndrome (SS) are relucatantly covered on this week's show EMCrit Project by Scott Weingart, MD FCCM.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
pharmaphorum
APRIL 17, 2025
A complaint against GSK alleging a major breach of the pharma industry's code of practice on prescribing information has been upheld by the PMCPA
World Pharma News
APRIL 17, 2025
A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of Alzheimers disease and related dementias in patients with Type 2 diabetes. In research published in JAMA Neurology on April 7, UF researchers studied Medicare claims data of older adults with Type 2 diabetes to assess the association among glucagon-like peptide-1 receptor agonists, or GLP-1RAs, sodium-gluc
pharmaphorum
APRIL 17, 2025
Shares in Eli Lilly rose sharply in pre-market trading today after it reported phase 3 results for oral diabetes and weight-loss drug orforglipron
Express Pharma
APRIL 17, 2025
What are the major advancements in drug development research? What are the opportunities for India in the current landscape? Drug development research has made remarkable progress globally, with India emerging as a key contributor. According to Deloitte, Indias pharmaceutical research and development (R&D) market is estimated to expand to $130 billion by 2030, and the country is considered the third-largest global producer of drugs by volume (1).
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
APRIL 17, 2025
Our round-up of recent biotech financings includes rounds for Merida, Glycomine, Attovia, Imbria, and Solu Therapeutics.
BioPharma Dive
APRIL 17, 2025
The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, swelling Lilly's market value by more than $100 billion.
pharmaphorum
APRIL 17, 2025
Spruce has bounced back from the failure of its lead drug last year, thanks to a licensing deal with BioMarin for a late-stage Sanfilippo drug
The Script
APRIL 17, 2025
Explore how self-leadership empowers pharmacy professionals to grow, lead, and deliver better care. Find your next opportunity with Rx relief.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
362 
Let's personalize your content